retatrutide making me feel sick Side Effects: Risks and Warnings Retatrutide, an experimental weight-loss drug,

Semaglutide : FDA-approved since 2017 for T2D, 2021 for obesity

Expiration and Shelf Life: Understanding when to discard tirzepatide

Your success doesnt end when you stop the medication

Medicare does not cover GLP-1 medications when prescribed for weight loss alone (CMS rules), though Medicare Part D plans may cover Ozempic, Mounjaro, or Wegovy when prescribed for type 2 diabetes or established cardiovascular disease

Importantly, patients should not discontinue GLP-1 therapy without medical guidance, as the benefits for diabetes management or weight loss typically outweigh the temporary inconvenience of hair shedding